T. Mazzei

S. Esposito, T. Mazzei, A. Novelli, 2001, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen.

T. Mazzei, P. Periti, 1999, Journal of chemotherapy.

Intraoperative Positive Fluid Balance Improves Tissue Diffusion of Ceftizoxime

A. Di Filippo, A. D. de Gaudio, T. Mazzei, 2005, Chemotherapy.

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients

A. Caraceni, S. Ricci, F. Masedu, 2018, Cancers.

Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors.

E. Mini, T. Mazzei, G. Amunni, 2018, Molecular and clinical oncology.

Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil.

F. Cianchi, M. Genuardi, L. Papi, 2011, Pharmacological research.

Antimicrobial Prophylaxis in Colorectal Surgery Results of a Prospective, Multicenter, Randomized Study

T. Mazzei, P. Periti, 2006 .

Single-dose cefotetanvs. Multiple-dose cefoxitin—Antimicrobial prophylaxis in colorectal surgery

T. Mazzei, F. Tonelli, P. Periti, 1989 .

Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study.

T. Mazzei, P. Periti, F. Tonelli, 1989, Diseases of the colon and rectum.

Chromosomal Characterization of Methotrexate-resistant Human T-lymphoblast Leukemia Cells (CCRF-CEM) with Impaired Polyglutamylation

R. Stanyon, E. Mini, T. Mazzei, 1991, Tumori.

Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?

Á. Soriano, F. Tenover, C. Liao, 2013, Journal of global antimicrobial resistance.

The Charta of Milan: Basic Criteria for the Appropriate and Accurate Use of Antibiotics: Recommendations of the Italian Society of Chemotherapy

I. Viano, A. De Sarro, F. Pea, 2009, Journal of chemotherapy.

eview ew insights into meticillin-resistant Staphylococcus aureus ( MRSA ) athogenesis , treatment and resistance

T. Mazzei, M. Goulda, M. Davidb, 2011 .

Pharmacological and Pharmacoeconomic Considerations

A. Moretti, F. Blasi, G. Tempera, 2010, Journal of chemotherapy.

Chemistry and mechanism of action of bleomycin.

T. Mazzei, 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

A survey on infection management practices in Italian ICUs

M. Antonelli, M. Bassetti, R. De Gaudio, 2012, Critical Care.

[Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].

A. Martoni, C. Pinto, E. Mini, 2001, Tumori.

Chemistry and mode of action of macrolides.

E. Mini, T. Mazzei, A. Novelli, 1993, The Journal of antimicrobial chemotherapy.

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.

F. Cianchi, C. Cortesini, M. Genuardi, 2005, European journal of cancer.

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

A. Marchese, K. Naber, H. Botto, 2009, International journal of antimicrobial agents.

Leuprorelin Acetate Depot in Advanced Prostatic Cancer: A Phase II Multicentre Trial

E. Mini, T. Mazzei, M. Rizzo, 1990, The Journal of international medical research.

Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate.

R. Saccardi, P. Bernabei, V. Santini, 1989, Journal of chemotherapy.

Ertapenem peritoneal fluid concentrations in adult surgical patients.

T. Mazzei, A. Novelli, F. Tonelli, 2009, International journal of antimicrobial agents.

Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II study.

C. Pinto, E. Mini, T. Mazzei, 2003, Anticancer research.

Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

L. Papucci, N. Schiavone, S. Capaccioli, 2006, Oncology research.

Clinical Pharmacokinetic Properties of the Macrolide Antibiotics

E. Mini, T. Mazzei, A. Novelli, 2012 .

Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.

F. Nozzoli, T. Mazzei, C. Marino, 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Azithromycin Concentrations in Serum and Bronchial Secretions of Patients with Cystic Fibrosis

T. Mazzei, A. Novelli, M. Cipolli, 2001 .

Tissue penetration and pulmonary disposition of tobramycin.

E. Mini, T. Mazzei, A. Novelli, 1995, Journal of chemotherapy.

Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides

S. Capaccioli, A. Quattrone, E. Mini, 2000, Anti-cancer drugs.

Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia.

J. Bertino, E. Mini, T. Mazzei, 1990, Journal of chemotherapy.

Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity.

L. Messori, E. Mini, T. Mazzei, 2001, Oncology research.

Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.

J. Bertino, E. Mini, T. Mazzei, 1987, Biochemical pharmacology.

Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu).

L. Messori, E. Mini, T. Mazzei, 2000, Chemico-biological interactions.

Gold(III) compounds as potential antitumor agents: Cytotoxicity and DNA binding properties of some selected polyamine-gold(III) complexes

L. Messori, E. Mini, T. Mazzei, 1998 .

Amoxicillin/Clavulanic Acid Versus Cefotaxime for Antimicrobial Prophylaxis in Abdominal Surgery: A Randomized Trial

T. Mazzei, A. Novelli, F. Tonelli, 2002, Journal of chemotherapy.

Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012.

M. Falagas, W. Ko, U. Theuretzbacher, 2013, Journal of global antimicrobial resistance.

Efficacy of Caspofungin against Aspergillus terreus

A. Santinelli, M. Rinaldi, A. Fothergill, 2005, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Drug Interactions of Macrolides

E. Mini, T. Mazzei, A. Novelli, 1992, Clinical pharmacokinetics.

Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents

E. Mini, T. Mazzei, S. Selleri, 2005, Anti-cancer drugs.

Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study

A. Caraceni, S. Ricci, F. Masedu, 2020, JCO precision oncology.

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.

L. Messori, E. Mini, M. Fontani, 2000, Journal of medicinal chemistry.

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.

L. Messori, M. Cinellu, E. Mini, 2002, Journal of medicinal chemistry.

Clinical Pharmacokinetics of Depot Leuprorelin

E. Mini, T. Mazzei, P. Periti, 2002, Clinical pharmacokinetics.

Cellular pharmacology of gemcitabine.

E. Mini, T. Mazzei, S. Nobili, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Cefodizime in Skin Suction Blister Fluid and Serum Following a Single Intravenous or Intramuscular Dose in Adult Patients

S. Esposito, S. Noviello, T. Mazzei, 2000, Journal of chemotherapy.

Infections in immunocompromised patients. II. Established therapy and its limitations.

T. Mazzei, P. Periti, 1985, Clinical therapeutics.

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

L. Di Francesco, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

Systemic absorption of 3H-fenticonazole after vaginal administration of 1 gram in patients.

R. Masi, T. Mazzei, A. Novelli, 1991, Journal of chemotherapy.

In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.

T. Mazzei, A. Novelli, S. Fallani, 1995, Journal of chemotherapy.

The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on Doripenem

T. Mazzei, Teresita Mazzei, 2010 .

Postantibiotic Leukocyte Enhancement of Meropenem against Gram-Positive and Gram-Negative Strains

T. Mazzei, A. Novelli, S. Fallani, 2000, Antimicrobial Agents and Chemotherapy.

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

I. Gould, S. Esposito, R. Cauda, 2011, International journal of antimicrobial agents.

Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.

R. De Gaudio, P. Pecile, T. Mazzei, 2008, International journal of antimicrobial agents.

Tissue distribution of antimicrobial drugs.

T. Mazzei, P. Periti, 1989, Journal of chemotherapy.

Pharmacokinetics of Dirithromycin in Patients with Mild or Moderate Cirrhosis

T. Mazzei, A. Novelli, M. Biagini, 1999, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.

T. Mazzei, P. Periti, P. Nicoletti, 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Human Pharmacokinetic and Pharmacodynamic Profiles of Leuprorelin Acetate Depot in Prostatic Cancer Patients

E. Mini, T. Mazzei, M. Rizzo, 1990, The Journal of international medical research.

Pharmacokinetics of azithromycin in patients with impaired hepatic function.

A. Crispo, T. Mazzei, A. Novelli, 1993, The Journal of antimicrobial chemotherapy.

Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.

T. Mazzei, A. Novelli, S. Fallani, 2006, International journal of antimicrobial agents.

New Insight into the Clinical Pharmacokinetics of Cefaclor: Tissue Penetration

S. Esposito, T. Mazzei, A. Novelli, 2000, Journal of chemotherapy.

Efficacy and safety of high dose intravenous ciprofloxacin in the treatment of bacterial pneumonia

T. Mazzei, P. Periti, M. Curti, 1998 .

Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.

L. Messori, E. Mini, T. Mazzei, 1998, Anti-cancer drug design.

Adverse Effects of Macrolide Antibacterials

E. Mini, T. Mazzei, A. Novelli, 1993, Drug safety.

Chemotherapy of Choriocarcinoma.

T. Mazzei, F. Gasparri, P. Periti, 1975 .

Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.

I. Gould, M. David, F. Scaglione, 2017, Journal of global antimicrobial resistance.

Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.

L. Papucci, S. Capaccioli, E. Mini, 1994, Oncology research.

Betalactam therapy and intestinal flora.

T. Mazzei, A. Novelli, R. Dei, 1995, Journal of chemotherapy.

Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.

S. Capaccioli, E. Mini, T. Mazzei, 1993, Biochemical and biophysical research communications.

RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

L. Messerini, A. Magi, A. Lapucci, 2019, International journal of cancer.

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

F. Cianchi, C. Cortesini, E. Mini, 2011, International journal of cancer.

Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

K. Naber, H. Botto, T. Mazzei, 2008, European urology.

Pharmacological aspects of the antibiotics used for urological diagnostic procedures

T. Mazzei, Sara Diacciati, 2014, Journal of chemotherapy.

Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

Ida Landini, Stefania Nobili, Enrico Mini, 2012, Medicinal research reviews.

Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns.

E. Mini, T. Mazzei, A. Novelli, 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

Clinical pharmacokinetics and tissue penetration of teicoplanin.

E. Mini, T. Mazzei, A. Novelli, 1989, International journal of clinical pharmacology research.

Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.

James T. Lin, E. Mini, T. Mazzei, 1988, Cancer research.

Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review.

T. Mazzei, P. Periti, 1998, Journal of chemotherapy.

Bimonthly Chemotherapy with Oxaliplatin, Irinotecan, Infusional 5-Fluorouracil/Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with Irinotecan- or Oxaliplatin-Based Chemotherapy

E. Mini, T. Mazzei, S. Nobili, 2008, Journal of chemotherapy.

Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin

T. Mazzei, G. Amunni, A. Villanucci, 2017, Anti-cancer drugs.

Modifications of moxifloxacin concentrations in plasma and tonsillar tissue after multiple administration in adults

S. Esposito, F. Passàli, L. Bellussi, 2003 .

First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer

F. Pannuti, A. Martoni, E. Mini, 2004, Investigational New Drugs.

Role of the Oral Beta-Lactams in the Treatment of Exacerbations of Chronic Bronchitis: Critical Analysis and Therapeutic Recommendations

A. Moretti, F. Blasi, G. Tempera, 2010, Journal of chemotherapy.

The pharmacokinetics of oral cephalosporins.

T. Mazzei, P. Dentico, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.

T. Mazzei, P. Periti, 1999, International journal of antimicrobial agents.

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)

E. Zecca, G. Fasola, A. Caraceni, 2016, Advances in Therapy.

Description of the Disease and Diagnostic and Epidemiologic Aspects

A. Moretti, F. Blasi, G. Tempera, 2010, Journal of chemotherapy.

Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration.

T. Mazzei, A. Novelli, P. Periti, 1996, The Journal of antimicrobial chemotherapy.

Etiology Issues and Problems of Antibiotic Resistance

A. Moretti, F. Blasi, G. Tempera, 2010, Journal of chemotherapy.

Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.

M. Eandi, L. Fioretto, E. Mini, 1989, Drugs under experimental and clinical research.

Intra-arterial hepatic chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer.

E. Mini, T. Mazzei, A. Valeri, 1994, Anticancer research.

Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay.

I. Cree, M. Pazzagli, P. Andreotti, 1995, Anti-cancer drugs.

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

R. Labianca, P. Conte, R. Rosso, 1994, European journal of cancer.

Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.

E. Mini, T. Mazzei, A. Pesciullesi, 1995, Anticancer research.

Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.

E. Mini, T. Mazzei, P. Periti, 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Urological Infections Due to Multidrug-Resistant Bacteria: What We Need to Know?

A. Salonia, M. Battaglia, T. Cai, 2016, Urologia.

Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.

F. Cianchi, C. Cortesini, S. Capaccioli, 1999, Oncology research.

Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma.

F. Pannuti, A. Martoni, E. Mini, 1991, Cancer investigation.

Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.

C. Pinto, E. Mini, T. Mazzei, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety Profile of the Fluoroquinolones

G. Mazzaglia, A. Vannacci, F. Lapi, 2010, Drug safety.

In Vivo Pharmacodynamic Evaluation of Clarithromycin in Comparison to Erythromycin

T. Mazzei, A. Novelli, S. Fallani, 2002, Journal of chemotherapy.

Pharmacokinetics and blister fluid penetration of brodimoprim in adults.

T. Mazzei, A. Novelli, P. Periti, 1993, Journal of chemotherapy.

Pharmacokinetic Evaluation of Meropenem and Imipenem in Critically Ill Patients with Sepsis

T. Mazzei, A. Novelli, C. Adembri, 2005, Clinical pharmacokinetics.

Amoxicillin/clavulanate in chronic rhinosinusitis: tissue and serum distribution.

D. Passali, L. Bellussi, C. Mezzedimi, 2001, Acta oto-rhino-laryngologica Belgica.

Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery.

T. Mazzei, P. Periti, F. Tonelli, 1993, Journal of chemotherapy.

Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.

A. Peri, F. Torricelli, M. Maggi, 1998, Gynecologic oncology.

Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery

T. Mazzei, A. Novelli, P. Periti, 1994, Antimicrobial Agents and Chemotherapy.

Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

E. Mini, T. Mazzei, S. Nobili, 2012, Medicinal research reviews.

Ertapenem peritoneal fluid concentrations in adult surgical patients.

T. Mazzei, A. Novelli, F. Tonelli, 2009, International journal of antimicrobial agents.

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

L. Di Francesco, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

F. Cianchi, C. Cortesini, E. Mini, 2011, International journal of cancer.

Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

K. Naber, H. Botto, T. Mazzei, 2008, European urology.

Principles of antimicrobial chemoprophylaxis in surgery.

T. Mazzei, P. Periti, 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.